In the present study, we analyzed the regulation of the anti-inflammatory and detoxifying CD163 receptor along with the antioxidant, Nrf2-induced enzymes HO-1 and NQO1 in patients with AAA. Here, NFE2L2 is linked to triple-A syndrome.